INTER PHARMA PUBLIC COMPANY LIMITEDSET: IP🇹🇭 TH

CG Policy · 2025

Corporate Governance Policy

Has a Corporate Governance Policy

Yes

Policy Description

The Company realizes the importance of good corporate governance, which is an important issue that promotes the Company's operations to be efficient and grow sustainably. That will lead to the utmost benefit to all stakeholders, from employees, investors, shareholders and other stakeholders. Therefore, the Board of Directors agrees that a better corporate governance policy should be established covering key principles from structure, roles, duties and responsibilities of the Board of Directors to the management principles of the executives providing transparent, transparent and verifiable to be a guideline for managing the organization and to make the belief that any operation of the Company is appropriate to the best interests of shareholders and all stakeholders. The Board of Directors places importance on compliance with good corporate governance principles; therefore, it has established a policy of Good Corporate Governance Policy in writing, which is prepared in accordance with the principles of the Corporate Governance Code for listed companies 2017 of the Office of the Securities and Exchange Commission as a guideline. The policy comprises 8 practices, as follows;

Principle 1: Establish a clear leadership role and responsibilities of the board

Principle 2: Define objectives that promote sustainable value creation

Principle 3: Strengthen board effectiveness

Principle 4: Ensure effective CEO and people management

Principle 5: Nurture innovation and responsible business

Principle 6: Strengthen effective risk management and internal control

Principle 7: Ensure disclosure and financial integrity

Principle 8: Ensure engagement and communication with shareholders

Policy Document Link

https://investor.interpharma.co.th/storage/downloads/corporate-governance/20250324-ip-cg-policy-en.pdf

Policy & Practices — Board of Directors

Has Policy & Guidelines for the Board

Yes

Board Guidelines

GuidelineDetail
Nomination of Directors

The Company places importance on a systematic and transparent process for the nomination and selection of directors in accordance with the principles of good corporate governance. The objective is to ensure that the Board of Directors comprises individuals with the appropriate knowledge, capabilities, experience, and qualifications to effectively oversee and guide the Company’s business operations. The Company has assigned the Nomination and Remuneration Committee to consider, screen, and nominate qualified individuals for directorship. In this process, the Committee takes into consideration the candidates’ qualifications, knowledge, expertise, experience, and skills that would be beneficial to the Company’s business operations. The overall structure of the Board is also considered in order to ensure an appropriate balance of skills and experience (Board Skill Matrix) aligned with the Company’s strategy and business direction. In nominating directors, the Company also takes into account Board Diversity in terms of knowledge, expertise, business experience, gender, age, and independence of directors, in order to enhance the effectiveness of corporate governance and strategic decision-making. Individuals nominated for directorship must possess the required qualifications and must not have any prohibited characteristics as prescribed by applicable laws, including the regulations of the Securities and Exchange Commission and the Stock Exchange of Thailand. The nominated candidates will be proposed to the Board of Directors for consideration before being submitted to the shareholders’ meeting for approval of the appointment in accordance with the prescribed procedures.

Determination of Director Remuneration

The Company has the policy to set the remuneration for directors to be in accordance with the Company's strategy and long-term goals by considering experience, duties, the scope of roles and responsibilities (accountability and responsibility), including expected benefits for directors who are assigned more duties and responsibilities. For example, being a member of a sub-committee will receive appropriate additional remuneration. The rate of remuneration of directors is comparable to other businesses in the same industry which the Board of Directors has assigned the Nomination and Remuneration Committee to consider the structure and rate of directors' remuneration, both monetary and non-monetary, to be appropriate both remuneration at a fixed rate (such as regular compensation meeting allowance) and remuneration according to the Company's performance (such as bonuses, gratuities) and propose to the Board of Directors meeting for consideration and present to the Shareholders’ Meeting for approval annually.

Independence of the Board of Directors from the Management

The Company places great importance on good corporate governance and aims to ensure that the Board of Directors can perform its oversight and advisory roles independently, transparently, and effectively. This is to maintain an appropriate balance between the roles of the Board of Directors and the management team. The Company has established a Board structure with an appropriate proportion of independent directors in accordance with the regulations of the Securities and Exchange Commission and the Stock Exchange of Thailand. Independent directors play an important role in providing checks and balances and overseeing the management’s operations. Independent directors are required to possess the qualifications and independence as prescribed by relevant laws and regulations, and must be able to express their opinions and provide recommendations on the Company’s business operations independently. In addition, the Company clearly separates the roles and responsibilities between the Board of Directors and the management team. The Board of Directors is responsible for setting policies, vision, strategies, and overseeing the Company’s operations, while the management team is responsible for managing and operating the business in accordance with the policies and strategies established by the Board. To further strengthen independent oversight, the Company has established subcommittees, such as the Audit Committee and the Nomination and Remuneration Committee, which mainly consist of independent directors. These committees are responsible for reviewing and providing opinions on important matters before submitting them to the Board of Directors for consideration. Furthermore, the Company supports the Board of Directors in having adequate and timely access to information necessary for the performance of their duties. The Board may also seek advice from external experts when appropriate to ensure that decisions are made prudently, transparently, and in the best interests of the Company and its shareholders as a whole.

Director Development

The Board of Directors supports and promotes knowledge development for the Board of Directors to attend various training courses which beneficial to the performance of the Board of Directors provide up-to-date knowledge, innovation, the new management style of business that is always competitive and able to apply knowledge appropriately. All directors of the Company attended the training course for directors from the Thai Institute of Directors (IOD) and regularly attend additional training courses, details are in the attached 1.

Board Performance Evaluation

The Company recognizes the importance of Board performance evaluation as an essential mechanism for enhancing the effectiveness of corporate governance. The evaluation process supports the Board of Directors in performing its duties with efficiency, transparency, and accountability, in alignment with the principles of good corporate governance.

The Company conducts an annual performance evaluation of the Board of Directors, covering multiple levels of assessment, including the evaluation of the Board as a whole, individual director self-assessment, sub-committee performance evaluation, and the performance evaluation of the Chief Executive Officer. The evaluation results serve as a key input for improving the Board’s effectiveness in providing strategic direction, overseeing management performance, and supporting the management in achieving the Company’s objectives. The evaluation forms are developed in accordance with the guidelines recommended by the Stock Exchange of Thailand and consist of four types as follows:

  1. Board of Directors Self-Assessment

  2. Individual Director Self-Assessment

  3. Sub-Committee Self-Assessment

  4. Chief Executive Officer Performance Evaluation

The evaluation results are expressed as a percentage of the total score and categorized into the following levels:

  • more than 91-100 % = excellent,

  • more than 81-90 % = very good,

  • more than 71-80 % = good,

  • more than 60-70 % = fair, and

  • less than 59 % = need improvement.

Corporate Governance of Subsidiaries and Associated Companies

1. The Company has the policy to invest in businesses that are related to the core business of the Company and that have the potential to generate profits and have growth opportunities to increase the Company's profitability or be beneficial businesses (synergy) to the Company by realizing the return that will be received from the investment through controlling and supervising the management of the subsidiary as if it were a unit of the Company. Also, it shall monitor the management to maintain the benefits of the Company's investments continuously and sustainably, create added value, and build confidence among the Company's stakeholders. Therefore, the Company has established a policy to control and supervise subsidiaries and associated companies that it has invested in with the following details. The Company has established the management structure of its subsidiaries and associated companies to oversee the management and be responsible for the operations of the subsidiaries and associated companies as follows:

Nomination of Individuals to be Directors and Executives of the Subsidiaries and Associated Companies

1.1 The Company will send individuals approved by the Board of Directors Meeting to be directors and executives in the subsidiaries and associated companies to supervise and establish the management policy as a part of the Company. The number of people who will join as directors in the subsidiaries are mainly based on the Company's shareholding in the subsidiaries or in accordance with an agreement. For investments in the associated companies, the Company needs the policy to control more. Submission of representatives to join as directors of the associated companies will be appropriately considered, depending on the agreement. Such individuals must have appropriate qualifications and experience in managing the business of such subsidiaries and associated companies.

1.2 Scope of Duties and Responsibilities of Directors and Executives in Subsidiaries and Associated Companies

  • Follow up the operations of the subsidiaries and associated companies closely to achieve the goals set by the Company.

  • Perform duties as assigned by the Board of Directors of the subsidiaries and associated companies and/or the Shareholders’ Meeting of the subsidiaries or associated companies.

  • Consider and vote at the Board of Director Meeting of the subsidiaries and associated companies in general operations of the subsidiaries and associated companies as the directors and executives of the subsidiaries and associated companies seem appropriate for the utmost benefit of the subsidiaries, associated companies, and the Company, except for consideration and voting on the following, which must be approved by the Board of Directors and/or the Company's Shareholders’ Meeting depending on the case before proceeding.

    (1) Transactions of the subsidiaries are in accordance with the notification of connected transactions and the notification of acquisition[1]and disposition[2].

    (2) Transactions that may have a significant impact on the finances and the subsidiaries’ operations are listed below:

  • Sell or transfer all or some significant portions of the subsidiaries to other people.

  • Purchase or accept the business transfer of other companies to be in the possession of the subsidiaries.

  • Dissolve the subsidiaries.

  • Transfer or waive significant benefits and claims that can cause damage to the subsidiaries.

  • Borrow money, lend, guarantee, encumber, or provide financial assistance to other companies that significantly affect the subsidiaries’ finances.

  • Revise the articles of association of the subsidiaries.

  • Capital increase, share allocation, and the reduction of the registered capital of the subsidiaries, as well as other actions that directly and indirectly cause the Company's shareholding to decrease from 10 % of the paid-up capital of

2. Directors and executives of the subsidiaries, including the related individuals of such directors and executives, are responsible for reporting to the Board of Directors of the subsidiaries about the relationship and transactions with subsidiaries in ways that may cause conflicts of interest and shall avoid entering into any transactions that may cause conflicts of interest with such subsidiaries. In this regard, the Board of Directors of the subsidiaries is responsible for reporting such matters to the Company.

Directors and executives of the subsidiaries must not participate in approving matters in which they have interests or conflicts of interest.

3. Subsidiaries are required to report business plans, investment projects, and joint ventures with other operators to the Company through the subsidiaries' monthly performance report including providing information or documents related to operations upon request. In the event that the Company detects any significant issues, it may notify the subsidiary to clarify and/or submit documents for consideration by the Company.

4. The Company has assigned financial control policies for subsidiaries and associated companies. The subsidiaries and associated companies have the duties as follows:

  • Submit monthly results and quarterly reviewed financial statements reviewed by a certified public accountant as well as supporting information for the preparation of such financial statements of subsidiaries and associated companies for the Company to support the preparation of the consolidated financial statements or report the Company's quarterly or annual performance, depending on circumstances.

  • Prepare overall operation estimates and summarize the comparison of the planned operation with the actual operation on a quarterly basis, including following up on the performance to be in accordance with the plan that has been set for reporting to the Company.

  • Report significant financial issues to the Company when they are discovered or be requested by the Company to carry out an investigation and report.

Policy & Practices — Shareholders and Stakeholders

Has Policy & Guidelines for Shareholders and Stakeholders

Yes

Shareholder & Stakeholder Guidelines

GuidelineOther — Please SpecifyDetailDocument LinkPage Number in Report
Shareholder

1. Practices to the Shareholders

The Company recognizes and places importance on the fundamental rights of shareholders By facilitating all shareholders to receive various fundamental rights both as an investor in securities and as a shareholder or owners of the Company with a standard method that is accepted and reliable by providing the right to purchase, sell, transfer the securities that they hold independ Association of the Company. Moreover, all shareholders shall have the right to vote according to the number of shares held, and each share is entitled to one vote, and no shares have special privileges over other shareholders.

In addition to the fundamental rights mentioned above, the Company has also undertaken various measures to promote and facilitate the exercise of shareholders’ rights for all groups of shareholders, including institutional investors, at the shareholders’ meetings as follows:

1.1 The Company has scheduled an Annual General Meeting of Shareholders within 4 months from the end of the Company's fiscal year. In case of urgent necessity, a special agenda must be proposed in which this affects or relates to the interests of shareholders or relates to conditions or rules and applicable laws that require approval from shareholders. The Company will call an extraordinary general shareholders’ meeting on a case-by-case basis. The meeting venue will provide the most suitable and convenient facilities for the shareholders and/or meeting via electronic media (E-Meeting).

1.2 The Company gives minority shareholders the right to propose matters to be considered as the meeting agenda. The shareholders can propose qualified persons to be elected as directors at the Annual General Meeting of Shareholders. The Company will announce and disseminate clear rules and procedures through the channels of the Stock Exchange of Thailand and on the Company website (www.interpharma.co.th). In this regard, the Board of Directors will inform the shareholders of the results of the consideration, together with reasons for acknowledgement.

1.3 The Company will send a meeting invitation letter together with supporting information for the meeting on various agendas with sufficient information to shareholders within 21 days prior to the meeting date, including published on the Company's website (www.interpharma.co.th) not less than days prior to the meeting date so that shareholders can consider the information before the meeting date.

1.4 The Company does not add any additional meeting agenda or change important information without notifying shareholders in advance, especially for significant issues that take time to consider before making a decision.

1.5 The Company provides an opportunity for shareholders to send questions for any information in each agenda, or other company information in advance of the meeting date.

1.6 Suppose shareholders cannot attend the meeting in person. In that case, the Company allows shareholders to authorize their representatives or an independent director as proposed to be a representative to attend the meeting on his/her behalf by utilizing the Company's proxy form as specified by the Ministry of Commerce. In addition, the shareholders can also download the proxy form through the Company's website.

1.7 The Company determines the meeting's date, time and venue, considering the convenience of attending the meeting. A barcode system is arranged for registration and vote processing for quick convenience and allows shareholders to register at least two hours before the meeting.

1.8 The Company encourages the Board of Directors, executives and relevant departments, including auditors to attend a shareholders' meeting.

1.9 The Company encourages the use of ballots for important agenda and encourages independent persons to count or verify votes in the shareholders' meeting. The results of the votes for approval, disapproval, and abstention for each agenda shall be disclosed to the meeting and recorded in the minutes of the meeting.

1.10 The meeting allows shareholders equal rights to express their opinions and make suggestions before voting on any agenda. In this regard, at the shareholders' meeting, there will be directors and executives who will answer questions. Essential questions and opinions shall be recorded in the meeting minutes for review.

1.11 The Company arranges for the recording of shareholders' meetings on tape. It prepares the minutes of the shareholders' meeting with accurate, complete information, including the recording of questions and answers at the meeting with the names and surnames of the questioners and respondents, as well as the voting results for each agenda, separated by the number of votes of shareholders who agree, disagree, abstain, and voided ballots. The names of the directors who participated in the meeting and those absent from the meeting are also recorded. A copy of the shareholders' meeting minutes shall be submitted to the Stock Exchange of Thailand and published on the Company's website (www.interpharma.co.th) within 14 days from the date of the shareholders' meeting for shareholders to review.

1.12 The Company places importance on the disclosure of accurate and timely information to investors, related parties, and the general public through the Stock Exchange of Thailand website or the Company's website. In addition, if shareholders have any questions or concerns, they can contact the Investor Relations Department by telephone at 02-634-0225 or by e-mail at ir@interpharma.co.th.co.th.

2. The Equitable Treatment of Shareholders

The Company has the policy to treat all shareholders and groups equally, whether major or minor shareholders, executive shareholders, or non-executive shareholders. The Company provides an opportunity for minority shareholders to nominate persons to be elected as directors in advance at a reasonable time, allowing shareholders unable to attend the meeting in person to exercise their voting rights by authorizing others to attend the meeting and vote on their behalf. Minority shareholders are also allowed to propose additional agenda items in advance of the meeting date. The details are as follows:

1.) Minority Shareholder Management

1.1 The Company takes care of minority shareholders. Minority shareholders can make suggestions, express opinions, notify of clues, or report complaints through the channels specified by the Company, such as postal mail, or deliver to the Chairman of the Board and/or the Chairman of the Audit Committee at the Company's address, by electronic mail (e-mail) at comsec@interpharma.co.th or via the Company's website at www.interpharma.co.th. The complaint receiver will consider taking appropriate action in each case or submit the case to the whistleblower investigator, who will be the person, group of people, or organization that has been considered appropriate, to consider independence in taking actions according to the content or issues received in complaints to investigate complaints or gather facts along with progress monitoring to ensure that appropriate action is taken in response to received complaints or cases where suggestions are deemed to be important issues affecting stakeholders as a whole or the Company's business. The matter will be proposed to the Board of Directors Meeting for consideration and set as an agenda item in the shareholders’ meeting.

1.2 The Company clearly sets the criteria for minority shareholders to propose additional meeting agendas in advance of the meeting date to show fairness and transparency in considering adding or not adding an agenda proposed by minority shareholders.

The qualifications of shareholders who will propose the above agenda are in accordance with Section 89/28 of the Securities and Exchange Act, which requires one or more shareholders who hold shares and have the right to vote in aggregate not less than 5% of the total number of voting rights of the Company and shall hold the Company's shares continuously from the date of holding until the date of proposing such an agenda for not less than 12 months and must hold the shares until the date of the Annual General Meeting of Shareholders. Such shareholders shall have the right to make a letter proposing the agenda to be included in the shareholders' meeting agenda, as mentioned above. In proposing an agenda for the Annual General Meeting of Shareholders, shareholders must specify the objectives and details of the proposed matter with useful information for consideration.

The Company reserves the right to refuse to include the matter in the meeting agenda in the following cases:

  1. Matters related to the normal business operations of the Company where the facts do not show any reasonable doubt about the abnormalities in such matters

  2. Matters beyond the Company's authority to proceed

  3. Matters required by laws to be considered by the shareholders' meeting that the Company has included in the agenda for every meeting

  4. Matters that are not beneficial to the Company's operations

  5. Matters contrary to laws, notices, regulations, rules, and regulations of government agencies or agencies that supervise the Company

  6. Matters that conflict with the objectives, regulations, resolutions of the shareholders' meeting, and good corporate governance principles of the Company

  7. Matters where the information provided by the shareholder is incomplete or incorrect; or when the Company requires additional information but cannot contact the shareholder who proposed the matter

  8. Matters previously proposed to the shareholders' meeting for consideration in the past 12 months and supported by votes of less than 10 % of the Company's total voting rights. The facts have mostly stayed the same from the facts at the time they were presented at the previous shareholders' meeting

  9. Matters that the Company has already proceeded

  10. there matters such as duplicated matters that have been proposed before, etc.

In the event that the shareholders fail to comply with the prescribed rules, the Company will inform the shareholders of such matters at that meeting of shareholders. The reason for the refusal to include such matters will be stated.

Proposals to be included in the agenda of the Annual General Meeting of Shareholders will be reviewed by the Company Secretary and presented to the Board of Directors for consideration and eventual inclusion in the agenda. The opinion of the Board of Directors shall be deemed final.

1.3 The procedure for minority shareholders to nominate candidates for the position of director is to make the nomination through the Company secretary at least 3 months prior to the meeting date, along with information for considering the qualifications and consent of the nominee.

The qualifications of shareholders to nominate a person for consideration as mentioned above are in accordance with Section 89/28 of the Securities and Exchange Act, which requires one or more shareholders holding shares and having voting rights in aggregate of not less than 5 % of the total number of voting rights of the Company. The shares must be held continuously from the date of shareholding until the date of proposing such an agenda for not less than 12 months. In addition, shareholders who hold shares until the date of the general meeting of shareholders have the right to nominate a person to be considered for election as a director of the Company.

A person who will be nominated for a director position must have all qualifications in accordance with the Public Company Limited Act, the Securities and Exchange Act, as well as the regulations of the Securities and Exchange Commission, the Capital Market Supervisory Board, the Stock Exchange of Thailand, and the Company's regulations, including other qualifications as specified by the Company. Qualifications of directors include knowledge, competence, expertise, and experience that can benefit and suit the nature of the business of the Company, have good work records, are independent, perform their duties with honesty, morality, and ethics, and be able to regularly attend the Board of Directors Meetings, etc.

Any person to be nominated as a director of the Company will be reviewed by the Nomination and Remuneration Committee and presented to the Board of Directors for consideration and submission to the Shareholders’ Meeting or not. The opinion of the Board of Directors shall be deemed final.

1.4 Shareholders are given the opportunity to exercise their rights to appoint individual directors. The selection and appointment of directors are in accordance with the method specified in the Company's articles of association. One shareholder has a vote equal to one share per vote, and in the election of directors, the voting method shall be used to select directors individually, and shareholders have the right to elect nominated candidates as directors, not exceeding the number of directors elected at that time. The votes cannot be split, even in the case of the election of several people as directors. The person receiving the highest number of votes in descending order will be elected as a director in an amount equal to the number of directors to be elected at that time. In the event that the candidates in subsequent order have equal votes, which would otherwise exceed the number of directors required or to be elected at that time, the chairman of the meeting shall have a casting vote. The shareholders' meeting must approve the appointed directors. The resolution of the shareholders' meeting is based on the majority vote of the shareholders who attend the meeting and have the right to vote.

1.5 The Company has the policy to add an agenda to the shareholders' meeting only if absolutely necessary, especially an important agenda requiring shareholders to study the information before making a decision. Therefore, the shareholders shall have the opportunity to consider the information pertaining to the agenda before making a decision. In this regard, it does not limit the right to attend the shareholders' meeting for those who are late, etc.

In 2025, the Company held the Annual General Meeting of Shareholders on April 28, 2025, via electronic means (E-Meeting) in accordance with the Emergency Decree on Electronic Meetings B.E. 2563 (2020) and other applicable laws. In addition, in line with the principles of good corporate governance, the Company provided shareholders with an opportunity to propose qualified individuals for consideration as directors of the Company, as well as to propose agenda items for inclusion in the agenda of the 2025 Annual General Meeting of Shareholders, in advance during the period from 1 October 2024 to 31 December 2024. Upon the expiration of such period, it appeared that no shareholders proposed any individuals for consideration as directors, nor were any agenda items proposed.

https://investor.interpharma.co.th/storage/downloads/corporate-governance/20250324-ip-coc-en.pdf9
Employee

The Company gives importance to employees as a valuable resource, strives to develop the abilities of all employees continuously, ensures the quality of their work lives is comparable to that of leading companies, and ensures employees are happy at work, feel pride, and create a bond with the organization. In the past, the Company has organized various projects to support and create a collaborative atmosphere, to create new things, to enhance the potential of employees to be ready for work, and to cope with situations in all aspects that may have a holistic impact. The Company also places great importance on maintaining health, safety, and the working environment, including appropriate compensation. The practices are as follows:

1. The Company shall take care and treat employees fairly and equally, respect human rights as well as give compensation to employees fairly and comparably to other industries at the same level, and provide appropriate welfare.

2. The Company places importance on the development of knowledge, abilities, and skills of employees by encouraging employees to receive training to sharpen their skills and knowledge thoroughly and regularly.

3. The Company shall avoid taking any unfair action that may threaten and put pressure on the mental status of employees or may affect the job security of employees.

4. The Company shall maintain the working environment to be safe for the life and assets of employees by providing an environment, occupational health, and safety in the workplace.

5. Appointment and transfer of employees, including rewards and punishments, shall be conducted with good faith d based on their knowledge, ability, and suitability.

6. The Company shall arrange to listen to opinions and suggestions, including providing channels for employees to file complaints in case of unfair treatment or giving clues about possible illegal acts. It shall have a corrective process as well as measures to protect such employees.

7. Employees shall strictly comply with applicable rules, regulations, and laws.

Customer

The Company is committed to continually improving the quality of products and services for customers to create higher customer satisfaction than expected. In this regard, the Company shall understand the customers’ needs and the Company to be able to offer services and meet the needs of customers appropriately as follows:

1. The Company shall deliver quality and standard products and services to customers within the specified timeframe and under fair conditions.

2. The Company shall provide complete, accurate, sufficient, and up-to-date information about the products and services of the Company to customers so that customers have enough information to decide without exaggerating both in advertising and in other communication channels, which causes customers to misunderstand the quality, quantity, or any conditions of the products or services.

3. The Company shall have customer confidentiality measures and not use the information for its own benefit or for those involved wrongfully.

4. The Company shall provide an efficient system and channels for customers to complain about the quality of products and services.

5. The Company shall strictly comply with various conditions towards customers. In the event that the conditions cannot be met, the action shall be notified to the customer in advance to consider finding solutions together.

6. Customer satisfaction is followed up and assessed in order to develop and improve products and services.

https://investor.interpharma.co.th/storage/downloads/corporate-governance/20250324-ip-coc-en.pdf10
Business competitor

The Company adheres to the framework of honest trade competition by adhering to conducting business with fairness within the framework of the laws and code of conduct. In the past, the Company did not have any disputes with business competitors. The practices are as follows:

1. Behave under the framework of good competition rules by adhering to the rules of fair competition, transparency, and not taking advantage.

2. Do not seek competitors' confidential information through a dishonest or inappropriate method.

3. Do not damage the reputation and accuse competitors of malicious accusations, fake news, or attacking competitors.

4. Do not agree with competitors or any person in a manner that reduces or limits the trade competition.

5. In dealing with commercial competitors, the Company’s employees shall not disclose or neglect the Company’s secrets to fall into the hands of competitors.

Business partner

The Company complies with the framework of honest trade competition and strictly adheres to the promises made to customers by adhering to fair contracts with partners, building trust, good relationships, and cooperation in order to develop potential and efficiency in long-term business cooperation, and having a policy of delivering products based on quality and on time. The practices are as follows:

1. The Company shall treat partners and/or creditors with equality and fairness, and based on fair returns to both parties. It shall strictly comply with the contracts or conditions that have been agreed upon. In the event that one of the conditions cannot be met, it shall notify business partners and/or creditors in advance to consider finding solutions together.

2. In business negotiations, executives and all employees should refrain from demanding, accepting, or paying any benefits that are dishonest in trading with business partners and/or creditors. If there is information that is any request, acceptance, or payment of dishonest benefits, the Company shall disclose details to business partners and/or creditors and solve problems fairly and rapidly together.

3. The Company shall regularly report an accurate and complete financial information to creditors in a timely manner.

Creditor

The Company keeps its commitments and strictly complies with its conditions and obligations to its creditors, including business creditors, financial institution creditors, etc. In addition, the Company participates in various activities and projects for its creditors to build good relationships with all creditors as well.

Government agency

The Company is committed to conducting business with honesty and compliance with laws, operating business with the government transparently and fairly as a normal customer, providing good confidence and cooperation with the public sector in order to solve problems, developing a good environment for society, and providing support to the public sector in various areas to create benefits for society and for the public.

Community and society

The Company will operate its business with ethics towards all stakeholders and is committed to improving the quality of life in every locality where it operates for social activities in various areas, including flood and disaster relief assistance. In addition, employees and related parties are encouraged to participate in being good citizens who benefit communities and society in order to grow together sustainably. Even during the economic crisis, the Company continues to carry out activities for the community and society by dedicating creativity, knowledge, and ability to enhance the effectiveness of social project management and cause maximum benefit to the community and society. The practices are as follows:

1. Support activities that are beneficial to society, community, and the environment.

2. Regularly return a part of the organization's profits to activities that shall contribute to society.

3. Do not take any action that has a detrimental effect on natural resources and the environment.

4. Cultivate consciousness in executives and employees of the Company to take social, community, and environmental responsibility to occur among employees at all levels continuously and consistently.

5. Control to ensure strict compliance with laws and regulations that are related to the environment, including supporting activities that are beneficial to society, community, and the environment on a regular basis.

6. Provide measures for saving energy saving and using resources efficiently and cost-effectively.

Other guidelines regarding shareholders and stakeholdersTreatment to Stakeholders

The Company has given importance to the rights of all stakeholders, whether internal stakeholders, such as shareholders, investors, or employees of the Company, and external stakeholders, such as customers, business partners, creditors, competitors, society, communities, etc. In operating the Company's business, it takes into account the rights of all stakeholders in accordance with the following guidelines:

1. Human Rights

  • The Company adheres to the principle of human rights as a common practice, taking into account human dignity, liberty, and equality of individuals and not encouraging human rights violations. The Company will not be involved with any agency, organization, or person that violates human rights and does not support activities that violate human rights principles.

  • The Company promotes respect for rights and freedoms through non-discrimination, equality for the underprivileged and persons with disabilities, equality of opportunity between men and women, no gender or class discrimination, and no child labor.

2. Respect for Intellectual Property

  • All employees shall have a duty to maintain trade secrets, including business information and other information related to the Company. Employees must protect all information as confidential information of the Company or business partners of the Company. The obligation to protect this information continues until the employee leaves the Company by arranging for an interview before leaving work and signing a written acknowledgment.

  • The Company will not disclose information without permission to the extent that it causes damage, and will be subject to legal liability for using copyrighted computer programs.

  • The Company does not solicit, obtain, or use business information obtained through unlawful or immoral means, nor does it infringe on the copyrights, patents, or trademarks of others.

Code of Conduct

Has a Business Code of Conduct

Yes

Code of Conduct Description

The Board of Directors has encouraged the preparation of a Business Code of Conduct for directors, executives, and employees to adhere to and perform with common responsibilities, including promoting the practice and monitoring such practice for the utmost benefit of the Company's stakeholders as well as creating credibility in business operations that will lead the Company to grow sustainably. The Board of Directors regularly reviews the Code of Business Ethics on an annual basis.

Code of Conduct Link

https://investor.interpharma.co.th/storage/downloads/corporate-governance/20250324-ip-coc-en.pdf

Page Number in Report

1-17

Code of Conduct Practices

GuidelineDetailDocument LinkPage Number in Report
Prevention of Misuse of Inside Information

1. Directors, executives, and employees of the Company and its subsidiaries shall perform duties for the best interest of the Company, avoid any action in a manner that may cause a conflict of interest whether from contacting with people involved in the business such as business partners, customers, competitors, r from using opportunities or information obtained from being a director, executive or employee for personal benefits, and avoid doing business that competes with the Company or work other than the work of the Company which affects work on duties, including not using customer information for personal benefits.

2. Executives and employees of the Company and its subsidiaries shall refrain from holding shares in competitors which make the employees act or omit actions that should be performed according to duties or have an impact on the work in the duties. In the case that the employees have acquired such shares before being an employee or before the Company enters into that business. Acquire through inheritance, employees shall report to their superiors in hierarchical order.

https://investor.interpharma.co.th/storage/downloads/corporate-governance/20250324-ip-coc-en.pdf6
Anti-corruption

Directors, executives, and employees of the Company and its subsidiaries are committed to opposing corruption both directly and indirectly, such as giving or accepting bribes or any incentives or entrusting others to give or accept bribes or incentives on behalf of themselves. Then, it requires all directors, executives, and employees to oppose corruption, including giving or accepting bribes strictly.

In this regard, the Company has prepared a written anti-corruption policy as a guideline for operating business and developing the organization towards sustainability. The Company requires that its anti-corruption policy, as well as guidelines and operational requirements, be regularly reviewed to ensure alignment with changes in business, rules, regulations, and applicable laws.

The Board of Directors reviews the anti-corruption policy on an annual basis, and in 2025, no complaints related to fraud or corruption were identified.

https://investor.interpharma.co.th/storage/downloads/corporate-governance/20220328-ip-cg-anti-corruption-th.pdf1-8
Whistleblowing and Protection of Whistleblowers

The Company has a policy to receive complaints and give opportunities to those suspected or affected by illegal acts, unethical conduct, acts that imply corruption, or behavior that may cause damage to the Company. There are channels for making complaints or reporting clues to the Company. The whistleblowers are those who have seen, known clues, or suspected in good faith whether or not they will be damaged or affected by the Company's business operations or from the performance of duties by directors, executives, and employees who violate or fail to comply with the laws and regulations of the state or with good corporate governance principles, business ethics, policies, and regulations of the Company, including actions that may imply corruption. Those who see violations can report such sightings to the Board of Directors through the channels specified by the Company. In this regard, the reported matter will be considered for further investigation. The Company protects the reporters in the best possible way. However, In 2025, no whistleblowing or complaints were found related to non-compliance with business ethics, corruption, or human rights violations.

Measures to Protect Whistleblowers or Complainants

  • The Company will keep the information and identity of the whistleblower or complainant confidential.

  • The Company will disclose information as necessary, taking into account the safety and damage of the whistleblower, the source of the information, or related persons.

  • Those who have been damaged will be compensated for damages through appropriate and fair procedures.

  • The Company will not take any unfair action against whistleblowers or complainants, whether by changing job titles, job descriptions, workplaces, work suspensions, layoffs, or any other actions that are unfair treatment to whistleblowers or complainants or cooperating in the fact-finding investigation.

Channels for Whistleblowing or Complaints About Misconduct or Any Complaints

  1. Postal mail, or deliver to:

Chairman of the Board and/or Chairman of the Audit Committee

Inter Pharma Public Company Limited

No. 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawong Sub-District, Bangrak District, Bangkok 10500

2. Electronic mail or e-mail at comsec@interpharma.co.th

3. Company website www.interpharma.co.th

Investigation Process and Punishment

The Company provides the opportunity for employees to have complaint channels and freely express their opinions as a guideline for development and sustainability for the organization as follows:

1. Upon receiving a whistleblower complaint, the Audit Committee will assign an internal auditor or appoint an investigation committee to screen and investigate the facts and periodically report the results of the investigation to the whistleblower or complainant.

2. Suppose the fact-finding investigation finds information or evidence that is reasonable to believe that the accused has committed an offense. In that case, the Company will give the accused the right to know the allegation and prove themself by obtaining additional information or evidence showing that they are not involved in the alleged offense.

3. If the accused has committed an offense, the offender, whether a director, executive, or employee, is considered an offender and will be subject to disciplinary action according to the regulations set by the Company. In addition, if the offense is against the law, the offender may be subject to legal penalties. According to the Company's regulations and the Audit Committee's decision, the disciplinary action is final.

4. As for reporting results, the Chairman of the Audit Committee, an independent director, or the Company Secretary shall report to the Board of Directors for acknowledgment and report to the stakeholders if the complainant reveals themself.

Preventing the Misuse of Inside Information

The Company and its subsidiaries recognize the importance of safeguarding the Company’s confidential and inside information. The Company has established a policy prohibiting directors, executives, and employees from disclosing or using any information that may affect the Company’s share price or any information that, if disclosed, could cause damage or disadvantage to the Company. Such information is considered confidential and material, including any undisclosed inside information. Directors, executives, and employees are strictly prohibited from using such information for personal benefit or for the benefit of others, whether directly or indirectly, and regardless of whether any consideration is received. In addition, they are prohibited from trading the Company’s securities based on inside information. To comply with the Securities and Exchange Act B.E. 1992 (as amended) and the regulations of the Stock Exchange of Thailand regarding information disclosure of listed companies, the Company has established guidelines to prevent the misuse of inside information.

Giving or receiving gifts, entertainment, or business entertainment

Directors, executives, and employees of the Company shall not solicit, accept, or agree to accept money, goods, or any other benefits from individuals who are business associates of the Company. However, directors, executives, and/or employees may customarily give or receive gifts, provided that the acceptance of such gifts does not affect any business decisions of the recipient, and the gifts received are of low value and should not be in the form of cash or cash equivalents. The Company has therefore established a policy and guidelines on the giving and receiving of gifts, hospitality, or any other benefits.

Compliance with laws, rules and regulations

All directors, executives, and employees of the company must strictly adhere to all company rules, policies, and regulations. Furthermore, in the operation of the Company, all directors, executives, and employees must strictly comply with all applicable laws, rules, and regulations governing the Company's operations. All directors, executives, and employees must have a thorough understanding of and be aware of all applicable laws, rules, and regulations governing the Company's operations, and regularly monitor any changes or amendments to these laws, rules, and regulations.

Use and maintenance of data and assets

All employees have the duty and responsibility to safeguard company assets, preventing damage or loss, and using them efficiently to maximize benefits for the company. They must not use company assets for their own benefit or the benefit of others. Furthermore, all employees must strictly avoid disclosing or misusing confidential information. Such assets include both tangible and intangible assets, such as movable property, immovable property, technology, academic knowledge, patents, copyrights, and confidential information not disclosed to the public, including business plans, financial forecasts, human resource data, etc.

Cyber security

1. Directors, executives, and employees of the company must maintain the confidentiality of company information and news that has not been publicly disclosed, and must not use such information for any improper gain. Furthermore, all directors, executives, and employees must strictly avoid disclosing or using confidential company information.

2. All directors, executives, and employees must maintain company confidentiality by taking care to prevent the leakage of confidential company documents or information to others, which could cause damage to the company. This includes not disclosing confidential company documents or information to external parties unless authorized by a supervisor.

3. The Company must safeguard and protect personal information received and exercise the utmost care in handling such information to maintain the privacy of the data subject. The Company will use personal information only for business purposes as disclosed to the data subject at the time of data collection.

Environmental management

The Company recognizes the importance of environmental protection and has implemented measures to safeguard the environment and conserve natural resources. These measures include: using resources wisely; reducing raw material consumption; minimizing energy use (for production, transportation, and offices); controlling water consumption; utilizing renewable resources; caring for and restoring biodiversity affected by business operations; managing and discharging waste generated from business operations; mitigating greenhouse gas emissions; and promoting the development of environmentally friendly products. Furthermore, the Company encourages the participation of all employees and stakeholders in environmental conservation.

Occupational health and safety

The Company promotes and prioritizes safety for its employees and stakeholders to prevent accidents, injuries, and work-related illnesses. It strives to eliminate or control unsafe conditions associated with its business operations by establishing the following Safety, Occupational Health, and Working Environment Policy:

1. The Company considers workplace safety a responsibility of all employees, who must cooperate to ensure their own safety, the safety of others, and the safety of company property at all times during work.

2. The Company will promote and support improvements to the working environment and work methods to ensure safety and good hygiene, thereby promoting the safety and health of employees.

3. The Company will promote and support various safety activities that raise employee awareness.

4. Supervisors at all levels must act as role models, lead, train, instruct, and oversee employees to ensure they perform their work safely and strictly adhere to safety regulations.

5. All employees must cooperate with the Company's safety and occupational health programs and have the right to offer suggestions for improving working conditions and safer working methods.

6. The Company will strictly comply with all relevant laws and regulations.

Promoting Compliance with the Code of Conduct

Promotes Compliance by Directors, Executives and Employees

Yes

Description

Compliance with Code of Business Conduct

The Company prescribes that it is the duties and responsibilities of the Board of Directors, executives, and all employees of the Company and its subsidiaries to acknowledge, understand, and strictly comply with the policies and procedures set forth in the "Code of Business Conduct." This is not voluntary, so they cannot claim that they are not aware of these established guidelines.

The Company has established guidelines for strengthening and supporting compliance with the Code of Business Conduct as follows:

  1. The written Code of Business Conduct is prepared and disseminated widely for executives and employees at all levels to read, understand, and sign for acknowledgment of this Code of Business Conduct as well as adhere to as the operational guideline.

  2. Executives at all levels in the Company shall take responsibility and place importance on ensuring that employees under their line management acknowledge, understand, and seriously comply with this Code of Business Conduct.

  3. Values are cultivated, and organizational culture is created to promote ethical values, including:

    • Directors and top executives of the Company shall be good role models in morality and ethics.

    • To understand the importance of morals and ethics shall be strengthened through activities in various forms.

  4. Guidelines for actions are set for any Code of Business Conduct problems, such as receiving complaints, investigation, protection of whistleblowers, and penalties.

5. The Code of Business Conduct is reviewed at least 1 time a year in order to ensure its suitability for the situation and changing business environment.

Receipt of Complaints about Code of Business Conduct

The Company has required all directors, executives, and employees to jointly monitor compliance with the Company's Code of Business Conduct. The Company has provided channels for complaints of violations or omissions to comply with the Company's Code of Business Conduct.

The Company shall keep the information received through the complaint channels confidential and treat it as confidential information. The complaint shall be protected from harassment during and after the investigation.

The Company shall deal with all complaints equally, transparently, and attentively, as well as being fair to all parties. The investigative period has been set appropriately and fairly.

Directors, executives, and employees witnessing any acts that violate or omit to comply with the Company's Code of Business Conduct can make complaints to the Company's complaint channels.

Process Document Link

https://investor.interpharma.co.th/storage/downloads/corporate-governance/20250324-ip-coc-en.pdf

Page Number in Report

13-14

Anti-Corruption Networks & Projects

Joined or Declared Intent to Join Anti-Corruption Networks

No

Networks & Projects Joined

Network / Project
Thai Private Sector Collective Action Against Corruption: CAC
United Nations Global Compact (UNGC)
Participation of anti-Corruption networks and initiatives

Material Changes & Developments in CG

Reviewed the CG Policy or Board Charter in the Past Year

Yes

Material Changes or Developments in the Past Year

Yes

Policy Review — Description

The Board of Directors regularly reviews the charters of the Board of Directors and its sub-committees, as well as key policies related to good corporate governance, on an annual basis.

In 2025, the Company formulated additional key policies and submitted them to the Board of Directors for consideration and approval, namely the Risk Management Policy, the Environmental Policy, and the Corporate Social Responsibility Policy, to ensure that the Company conducts its business in accordance with good corporate governance practices and sustainable business development, as well as in compliance with applicable rules, regulations, and relevant laws.

Implements the CG Code for Listed Companies

No

CG Code — Description

The Company gives importance to good corporate governance; therefore, relevant policies and guidelines have been specified in the Company's Corporate Governance Policy and Business Code of Conduct, as well as promoting actual practice to build confidence among all groups of stakeholders. During the past year, the Company monitored and ensured compliance with good corporate governance practices covering the following matters:

1) Employee care and non-discrimination

2) Anti-unfair competition

3) Caring for the environment, health, and safety in the organization

4) Information security

5) Human Rights

6) Anti-Corruption.

The monitoring results indicate that the Company has fully implemented the guidelines for each respective issue.

Other CG Performance & Outcomes

1. The Company received a full score of 100 points in the AGM Checklist assessment under the Annual General Meeting Quality Assessment Program for 2025, organized by the Thai Investors Association.

2. The Company received the results of the Corporate Governance Survey under the Corporate Governance Survey of Listed Companies for the year 2025, organized by the Thai Institute of Directors (IOD) with the support of the Stock Exchange of Thailand and the Securities and Exchange Commission (SEC). The Company was rated “Excellent” (5 stars) for its compliance with the principles of corporate governance for listed companies.

3. The Company applied to participate in the Listed Company Value Enhancement Program (JUMP+), organized by the Stock Exchange of Thailand, on 20 August 2025, to foster sustainable growth and enhance long-term value for the Company.

Contents